Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Serina Therapeutics, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $0.00 | $0.00 - $0.00 | $0.00 | -$1.49 | 0 |
| Dec 2029 | $0.00 | $0.00 - $0.00 | $0.00 | -$1.34 | 0 |
| Dec 2028 | $0.00 | $0.00 - $0.00 | $0.00 | -$1.02 | 0 |
| Dec 2027 | $0.00 | $0.00 - $0.00 | $0.00 | -$1.26 | 0 |
| Dec 2026 | $0.00 | $0.00 - $0.00 | $0.00 | -$1.84 | 0 |
| Dec 2025 | $130.0K | $130.0K - $130.0K | -$9.2K | -$2.08 | 1 |
| Dec 2024 | $100.0K | $100.0K - $100.0K | -$7.1K | $0.24 | 1 |